A-MARK PRECIOUS METALS INC (AMRK)

US00181T1079 - Common Stock

27.78  +0.38 (+1.39%)

After market: 28 +0.22 (+0.79%)

Fundamental Rating

4

Taking everything into account, AMRK scores 4 out of 10 in our fundamental rating. AMRK was compared to 15 industry peers in the Distributors industry. AMRK has a medium profitability rating, but doesn't score so well on its financial health evaluation. AMRK has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

AMRK had positive earnings in the past year.
In the past year AMRK has reported a negative cash flow from operations.
AMRK had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AMRK reported negative operating cash flow in multiple years.

1.2 Ratios

AMRK has a Return On Assets of 2.89%. This is comparable to the rest of the industry: AMRK outperforms 50.00% of its industry peers.
AMRK has a Return On Equity of 9.61%. This is comparable to the rest of the industry: AMRK outperforms 50.00% of its industry peers.
AMRK has a Return On Invested Capital of 3.04%. This is in the lower half of the industry: AMRK underperforms 64.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMRK is significantly below the industry average of 21.97%.
The 3 year average ROIC (9.40%) for AMRK is well above the current ROIC(3.04%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.89%
ROE 9.61%
ROIC 3.04%
ROA(3y)7.68%
ROA(5y)8.09%
ROE(3y)21.5%
ROE(5y)27.74%
ROIC(3y)9.4%
ROIC(5y)9.18%

1.3 Margins

AMRK has a Profit Margin (0.59%) which is comparable to the rest of the industry.
AMRK's Profit Margin has improved in the last couple of years.
AMRK's Operating Margin of 0.62% is on the low side compared to the rest of the industry. AMRK is outperformed by 64.29% of its industry peers.
In the last couple of years the Operating Margin of AMRK has grown nicely.
With a Gross Margin value of 1.68%, AMRK is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of AMRK has grown nicely.
Industry RankSector Rank
OM 0.62%
PM (TTM) 0.59%
GM 1.68%
OM growth 3Y-27.47%
OM growth 5Y98.04%
PM growth 3Y-30.4%
PM growth 5Y72.71%
GM growth 3Y-13.51%
GM growth 5Y21.7%

3

2. Health

2.1 Basic Checks

AMRK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AMRK has less shares outstanding
AMRK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMRK has an improved debt to assets ratio.

2.2 Solvency

AMRK has an Altman-Z score of 5.98. This indicates that AMRK is financially healthy and has little risk of bankruptcy at the moment.
AMRK's Altman-Z score of 5.98 is fine compared to the rest of the industry. AMRK outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 1.51 is on the high side and indicates that AMRK has dependencies on debt financing.
The Debt to Equity ratio of AMRK (1.51) is worse than 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF N/A
Altman-Z 5.98
ROIC/WACC0.32
WACC9.46%

2.3 Liquidity

A Current Ratio of 1.66 indicates that AMRK should not have too much problems paying its short term obligations.
AMRK's Current ratio of 1.66 is on the low side compared to the rest of the industry. AMRK is outperformed by 64.29% of its industry peers.
AMRK has a Quick Ratio of 1.66. This is a bad value and indicates that AMRK is not financially healthy enough and could expect problems in meeting its short term obligations.
AMRK has a worse Quick ratio (0.37) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.37

5

3. Growth

3.1 Past

The earnings per share for AMRK have decreased strongly by -67.11% in the last year.
Measured over the past years, AMRK shows a very strong growth in Earnings Per Share. The EPS has been growing by 69.05% on average per year.
The Revenue has been growing slightly by 0.59% in the past year.
AMRK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.19% yearly.
EPS 1Y (TTM)-67.11%
EPS 3Y-40.58%
EPS 5Y69.05%
EPS Q2Q%-51.95%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y8.41%
Revenue growth 5Y15.19%
Sales Q2Q%9.28%

3.2 Future

AMRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.79% yearly.
The Revenue is expected to grow by 0.74% on average over the next years.
EPS Next Y21.32%
EPS Next 2Y37.26%
EPS Next 3Y31.31%
EPS Next 5Y24.79%
Revenue Next Year6.32%
Revenue Next 2Y4.32%
Revenue Next 3Y-1.89%
Revenue Next 5Y0.74%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.97, the valuation of AMRK can be described as correct.
AMRK's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.09. AMRK is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 6.89, the valuation of AMRK can be described as very cheap.
Based on the Price/Forward Earnings ratio, AMRK is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.45. AMRK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.97
Fwd PE 6.89

4.2 Price Multiples

AMRK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.64

4.3 Compensation for Growth

AMRK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMRK's earnings are expected to grow with 31.31% in the coming years.
PEG (NY)0.75
PEG (5Y)0.23
EPS Next 2Y37.26%
EPS Next 3Y31.31%

5

5. Dividend

5.1 Amount

AMRK has a Yearly Dividend Yield of 3.03%.
In the last 3 months the price of AMRK has falen by -36.89%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
AMRK's Dividend Yield is rather good when compared to the industry average which is at 2.80. AMRK pays more dividend than 85.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, AMRK pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.03%

5.2 History

On average, the dividend of AMRK grows each year by 72.09%, which is quite nice.
AMRK has been paying a dividend for over 5 years, so it has already some track record.
The dividend of AMRK decreased in the last 3 years.
Dividend Growth(5Y)72.09%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

31.48% of the earnings are spent on dividend by AMRK. This is a low number and sustainable payout ratio.
AMRK's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.48%
EPS Next 2Y37.26%
EPS Next 3Y31.31%

A-MARK PRECIOUS METALS INC

NASDAQ:AMRK (1/2/2025, 8:12:19 PM)

After market: 28 +0.22 (+0.79%)

27.78

+0.38 (+1.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners65.11%
Inst Owner Change9.26%
Ins Owners15.62%
Ins Owner Change-1.43%
Market Cap643.94M
Analysts78.18
Price Target45.49 (63.75%)
Short Float %11.97%
Short Ratio7.08
Dividend
Industry RankSector Rank
Dividend Yield 3.03%
Dividend Growth(5Y)72.09%
DP31.48%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.33%
Min EPS beat(2)-58.5%
Max EPS beat(2)-16.17%
EPS beat(4)0
Avg EPS beat(4)-43.42%
Min EPS beat(4)-69.98%
Max EPS beat(4)-16.17%
EPS beat(8)2
Avg EPS beat(8)-21.06%
EPS beat(12)6
Avg EPS beat(12)-0.57%
EPS beat(16)10
Avg EPS beat(16)27.09%
Revenue beat(2)1
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-8.98%
Max Revenue beat(2)1.5%
Revenue beat(4)2
Avg Revenue beat(4)2.39%
Min Revenue beat(4)-8.98%
Max Revenue beat(4)25.88%
Revenue beat(8)5
Avg Revenue beat(8)8.16%
Revenue beat(12)6
Avg Revenue beat(12)3.98%
Revenue beat(16)9
Avg Revenue beat(16)4.56%
PT rev (1m)0%
PT rev (3m)-4.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)23.23%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 15.97
Fwd PE 6.89
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 2.06
EV/EBITDA 12.64
EPS(TTM)1.74
EY6.26%
EPS(NY)4.03
Fwd EY14.51%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS428.37
BVpS26.36
TBVpS13.52
PEG (NY)0.75
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 9.61%
ROCE 5.91%
ROIC 3.04%
ROICexc 3.13%
ROICexgc 3.86%
OM 0.62%
PM (TTM) 0.59%
GM 1.68%
FCFM N/A
ROA(3y)7.68%
ROA(5y)8.09%
ROE(3y)21.5%
ROE(5y)27.74%
ROIC(3y)9.4%
ROIC(5y)9.18%
ROICexc(3y)9.72%
ROICexc(5y)9.77%
ROICexgc(3y)11.49%
ROICexgc(5y)11.69%
ROCE(3y)22.11%
ROCE(5y)23.12%
ROICexcg growth 3Y-34.4%
ROICexcg growth 5Y100.78%
ROICexc growth 3Y-33.9%
ROICexc growth 5Y92.53%
OM growth 3Y-27.47%
OM growth 5Y98.04%
PM growth 3Y-30.4%
PM growth 5Y72.71%
GM growth 3Y-13.51%
GM growth 5Y21.7%
F-Score3
Asset Turnover4.89
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF N/A
Debt/EBITDA 12.34
Cap/Depr 108.81%
Cap/Sales 0.15%
Interest Coverage 1.67
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.37
Altman-Z 5.98
F-Score3
WACC9.46%
ROIC/WACC0.32
Cap/Depr(3y)75.66%
Cap/Depr(5y)56.13%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.11%
EPS 3Y-40.58%
EPS 5Y69.05%
EPS Q2Q%-51.95%
EPS Next Y21.32%
EPS Next 2Y37.26%
EPS Next 3Y31.31%
EPS Next 5Y24.79%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y8.41%
Revenue growth 5Y15.19%
Sales Q2Q%9.28%
Revenue Next Year6.32%
Revenue Next 2Y4.32%
Revenue Next 3Y-1.89%
Revenue Next 5Y0.74%
EBIT growth 1Y-63.51%
EBIT growth 3Y-21.37%
EBIT growth 5Y128.12%
EBIT Next Year33.76%
EBIT Next 3Y31.79%
EBIT Next 5Y21.83%
FCF growth 1Y-114.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.57%
OCF growth 3YN/A
OCF growth 5YN/A